Landscapes / Targets
NTRK
6 drugs act on NTRK, in 9 active trials · Any stage · updated 19 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs6
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
ROS1/TRK/ALK inhibitor |
Bristol Myers Squibb · Public BMY |
Approved | 16 Feb 2027Phase 3 trial completes | ||
| Next date | 16 Feb 2027 · Phase 3 trial completes | ||||
| Also tested for | Locally Advanced Solid Tumors, Metastatic Solid Tumors and 3 more | ||||
| Open drug page | |||||
Kinase inhibitor |
Approved | — | |||
| How it works | Blocks a kinase | ||||
| Open drug page | |||||
— |
Phase 2 | Dec 2027Phase 2 trial completes | |||
| Next date | Dec 2027 · Phase 2 trial completes | ||||
| Also tested for | Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 2 | 30 Jun 2028Phase 2 trial completes | |||
| Next date | 30 Jun 2028 · Phase 2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Idiopathic Pulmonary Fibrosis (IPF) | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Locally Advanced or Metastatic Solid Tumors, Locally Advanced or Metastatic Non-small Cell Lung Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Dec 2027Phase 1 trial completes | |||
| Next date | 30 Dec 2027 · Phase 1 trial completes | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 6 of 6 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026